Patents by Inventor Baohong Zhang

Baohong Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11535674
    Abstract: The present disclosure discloses a method for expressing and preparing a bivalent bispecific antibody. In the present disclosure, each portion of a bivalent bispecific antibody and an immune hybrid protein thereof is respectively expressed in a suitable prokaryotic or eukaryotic cell system, separated and purified by high-performance affinity chromatography, and then spliced in vitro by trans-splicing reaction mediated by an intein, to prepare the bivalent specific antibody and an immune hybrid protein thereof.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: December 27, 2022
    Assignees: SHANGHAI JIAO TONG UNIVERSITY, JECHO LABORATORIES INC., JECHO BIOPHARMACEUTICALS CO LTD.
    Inventors: Lei Han, Jianwei Zhu, Junsheng Chen, Kai Ding, Yueqing Xie, Hua Jiang, Huili Lu, Baohong Zhang, Lei Zhang
  • Patent number: 11326185
    Abstract: The present invention relates to stable and high-producing site-specific integration (SSI) host cells, e. g. Chinese hamster ovary (CHO)-derived host cells, methods to produce and to use them.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: May 10, 2022
    Assignees: LONZA BIOLOGICS PLC, PFIZER INC.
    Inventors: James Rance, Robert Young, Michael J. Agostino, Mark Moffat, Lin Zhang, Baohong Zhang
  • Publication number: 20200317819
    Abstract: The present disclosure relates to the field of biological technologies, and discloses a method for expressing and preparing a polyvalent multi-specific antibody and an immune hybrid protein. By using the characteristics of protein Intein, a novel method for preparing a polyvalent specific antibody, a hybrid immune protein having an antibody fused to a cytokine, an immunotoxin having an antibody fused to a toxin, or an immune hybrid protein having an antibody fused to other active proteins is designed and developed. Each portion of a hybrid protein is respectively expressed in a suitable prokaryotic or eukaryotic cell system, separated and purified by high-performance affinity chromatography, and then spliced in vitro by trans-splicing mediated by the intein, to prepare a polyvalent specific antibody and an immune hybrid protein. The method has high production efficiency, and wide scope of application, and facilitates the separation and purification of the products.
    Type: Application
    Filed: December 16, 2016
    Publication date: October 8, 2020
    Inventors: Jianwei ZHU, Lei HAN, Junsheng CHEN, Kai DING, Yueqing XIE, Hua JIANG, Huili LU, Baohong ZHANG, Lei ZHANG
  • Patent number: 10280436
    Abstract: The present invention relates to stable and high-producing site-specific integration (SSI) host cells, e. g. Chinese hamster ovary (CHO)-derived host cells, methods to produce and to use them.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: May 7, 2019
    Assignees: LONZA BIOLOGICS PLC, PFIZER INC.
    Inventors: James Rance, Robert Young, Michael J. Agostino, Mark Moffat, Lin Zhang, Baohong Zhang
  • Publication number: 20190119702
    Abstract: The present invention relates to stable and high-producing site-specific integration (SSI) host cells, e. g. Chinese hamster ovary (CHO)-derived host cells, methods to produce and to use them.
    Type: Application
    Filed: October 31, 2018
    Publication date: April 25, 2019
    Applicants: LONZA BIOLOGICS PLC, PFIZER INC.
    Inventors: James RANCE, Robert YOUNG, Michael J. AGOSTINO, Mark MOFFAT, Lin ZHANG, Baohong ZHANG
  • Publication number: 20190062434
    Abstract: The present disclosure relates to the field of biological technologies, and discloses a method for expressing and preparing a bivalent bispecific antibody. In the present disclosure, each portion of a bivalent bispecific antibody and an immune hybrid protein thereof is respectively expressed in a suitable prokaryotic or eukaryotic cell system, separated and purified by high-performance affinity chromatography, and then spliced in vitro by trans-splicing reaction mediated by an intein, to prepare the bivalent specific antibody and an immune hybrid protein thereof. The method has high production efficiency and wide scope of application, and facilitates the separation and purification of the products. The product prepared through the present method has bivalent bispecific immune affinity and cytotoxic bioactivity. Therefore, the present disclosure provides a novel method for preparing biological drugs for directionally attacking cancers or other diseases.
    Type: Application
    Filed: December 16, 2016
    Publication date: February 28, 2019
    Inventors: Lei HAN, Jianwei ZHU, Junsheng CHEN, Kai DING, Yueqing XIE, Hua JIANG, Huili LU, Baohong ZHANG, Lei ZHANG
  • Publication number: 20150167020
    Abstract: The present invention relates to stable and high-producing site-specific integration (SSI) host cells, e.g. Chinese hamster ovary (CHO)-derived host cells, methods to produce and to use them.
    Type: Application
    Filed: June 20, 2013
    Publication date: June 18, 2015
    Applicants: LONZA BIOLOGICS PLC, PFIZER INC.
    Inventors: James Rance, Robert Young, Michael J. Agostino, Mark Moffat, Lin Zhang, Baohong Zhang